NCT01616004UnknownNot Applicable
Effect of Acute Treatment With N2O on Inhibitory Pain Mechanisms in Healthy Subject
Tel-Aviv Sourasky Medical Center1 site in 1 country10 target enrollmentStarted: October 2014Last updated:
Conditions
Interventions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Enrollment
- 10
- Locations
- 1
- Primary Endpoint
- Pain Scores on the Visual Analog Scale
Study Overview
Brief Summary
The purpose of this study is to determine whether N2O (laughing gas) has an antinociceptive effects in healthy volunteers.
Detailed Description
10 healthy volunteers will come twice to the pain medicine unit, at 1 visit they'll get N2O and in the second visit they'll get air as placebo, they won't know what they're getting. During the visit they'll get heat stimulus using QST and will have to report their pain using eVAS (scale from 0 to 100 when 0 is no pain and 100 is the worst pain imagine).
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Basic Science
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 18 Years to 50 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •18-50 years old
- •women and men
Exclusion Criteria
- •medication use pregnant woman cardiovascular disease
Arms & Interventions
Air
Sham Comparator
Intervention: Air (Drug)
N2O
Experimental
N20 70% inhalation 5 minutes O2 100 % inhalation for 5 minutes
Intervention: N2O (Drug)
Outcomes
Primary Outcomes
Pain Scores on the Visual Analog Scale
Time Frame: August 2016
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Phase 2
Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg UlcersVenous UlcersNCT00613808Nitric BioTherapeutics, Inc6
Completed
Not Applicable
Validation of analgesic effect of nitrous oxide in neonates and infantsISRCTN71821503Department of Health270
Completed
Phase 2
Effects of Subanesthetic Concentrations of Nitrous Oxide - 1Opioid-Related DisordersSubstance-Related DisordersNCT00000249University of Chicago10
Completed
Not Applicable
Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK)Allergic AsthmaNCT00421018Karolinska Institutet187
Completed
Phase 1
Nitrite Infusion in Healthy VolunteersHealthyNCT00103025National Institute of Neurological Disorders and Stroke (NINDS)12